Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

BET-IN-13

BET-IN-13 is a potent BET inhibitor with an IC50 value of 1.6 nM. BET-IN-13 reduces LPS-induced TNF-α, IL-1β, IL-6, and NOS2 mRNA expression levels. BET-IN-13 shows anti-inflammatory activity. BET-IN-13 has the potential for the research of acute liver injury[1].

Product Specifications

CAS Number

[2506823-08-9]

UNSPSC

12352005

Target

Epigenetic Reader Domain

Type

Reference compound

Related Pathways

Epigenetics

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/bet-in-13.html

Solubility

10 mM in DMSO

Smiles

CC1=C2C(NC=C3CN(C4=C(C(N32)=C1)C=C(C=C4)CS(C)(=O)=O)C(C5=CC=C6C=CC=CC6=C5)=O)=O

Molecular Formula

C28H23N3O4S

Molecular Weight

497.56

References & Citations

[1]Chen C, et al. Cyclization strategy leads to highly potent Bromodomain and extra-terminal (BET) Bromodomain inhibitors for the treatment of acute liver injury. Eur J Med Chem. 2022 Dec 16;247:115023.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

BRD2; BRD3; BRD4; BRDT

More Discoveries

Explore Other Products

Browse additional items from our catalog

HIP1 (NM_001243198) Human Tagged ORF Clone
RC235103 10 µg

HIP1 (NM_001243198) Human Tagged ORF Clone

Sign In for Pricing
View Details
TAC1 Rabbit Polyclonal Antibody
TA363948 500 Tests

TAC1 Rabbit Polyclonal Antibody

Sign In for Pricing
View Details
CLDN5 Antibody, FITC conjugated
MBS7103759-01 0.05 mg

CLDN5 Antibody, FITC conjugated

Sign In for Pricing
View Details
CLDN5 Antibody, FITC conjugated
MBS7103759-02 0.1 mg

CLDN5 Antibody, FITC conjugated

Sign In for Pricing
View Details
CLDN5 Antibody, FITC conjugated
MBS7103759-03 5x 0.1 mg

CLDN5 Antibody, FITC conjugated

Sign In for Pricing
View Details
ACA-PEG-OH, 3.4K
HE010002-3.4K-01 1 g

ACA-PEG-OH, 3.4K

Sign In for Pricing
View Details